Triple Combination + Closantel (Liverfluke) drench for sheep
Active Constituents: Abamectin 1.0 g/L, Albendazole 25.0 g/L, Closantel 37.5 g/L, Levamisole hydrochloride 40.0 g/L
For the treatment and control in sheep of susceptible gastro-intestinal roundworms It is also effective against lungworm, tapeworms, mature and late immature liver fluke, nasal bot and itch mite.
Adult and immature gastrointestinal roundworms:
Barber’s Pole Worm Haemonchus contortus - including inhibited L4 stage and strains with single, dual or triple resistance to macrocyclic lactones, benzimidazoles, levamisole or closantel, and strains with emerging resistance to closantel.
Small Brown Stomach Worm Teladorsagia (Ostertagia) circumcincta
- including inhibited L4 stage and strains with single or dual resistance to macrocyclic lactones, benzimidazoles or levamisole:
Black Scour Worm
Trichostrongylus colubriformis - including strains with single or dual resistance to macrocyclic lactones, benzimidazoles or levamisole.
Nasal Bot Oestrus ovis
Lungworm Dictyocaulus viviparus (Large lungworm)
Liver Fluke Fasciola hepatica - mature fluke and immature forms including 6 week old stages. Reduces the output of viablefluke eggs.
Tapeworms Monezia spp - heads and segments
Itch mite Psorergates ovisTreat all animals on arrival, or ideally at farm of origin, and hold in yards for 24 hours before release. For use in a strategic worm control program:
Speak to your animal health adviser or veterinarian. Administer orally
DOSE RATE 1ml per 5kg bodyweight
| Live weight | Dose Rate | 10L treats |
| 21 - 25kg | 5ml | 2000 |
| 26 - 30kg | 6ml | 1666 |
| 31 - 35kg | 7ml | 1428 |
| 36 - 40kg | 8ml | 1250 |
| 41 - 45kg | 9ml | 1111 |
| 46 - 50kg | 10ml | 1000 |
| 51 - 55kg | 11ml | 909 |
| 56 - 60kg | 12ml | 833 |
| 61 - 65kg | 13ml | 769 |
| 66 - 70kg | 14ml | 714 |
| 71 - 75kg | 15ml | 666 |
Shake well before use
MEAT: Do NOT use less than 28 days before slaughter for human consumption.
MILK: Milk intended for sale or human consumption must be discarded for 35 days following treatment.
Registered pursuant to the ACVM Act 1997, No. A9291